SI
AMRX icon

Scout Investments’s Amneal Pharmaceuticals AMRX Stock Holding History

Scout Investments’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-108,059
Closed -$1.46M – 280
2018
Q4 		$1.46M Sell
108,059
-1,000
-0.9% -$18K 0.04% 258
2018
Q3 		$2.42M Buy
109,059
+2,295
+2% +$48.3K 0.05% 270
2018
Q2 		$1.75M Buy
+106,764
New +$1.87M 0.04% 267

Other funds holding AMRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
TG
TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Scout Investments's AMRX Position: Q1 2019 in Review

Scout Investments sold out of Amneal Pharmaceuticals (AMRX) in Q1 2019, closing a stake of 108,059 shares — an estimated $1.46M sold.

Scout Investments first reported a position in AMRX in Q2 2018 and held it in 3 quarters. The position peaked at $2.42M in Q3 2018. 164 funds tracked by Wall St. Rank hold AMRX as of Q1 2019.

  • Scout Investments reported no remaining Amneal Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Scout Investments sold 108,059 Amneal Pharmaceuticals shares in Q1 2019, an estimated $1.46M.
  • Scout Investments first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • Scout Investments's Amneal Pharmaceuticals position peaked at $2.42M in Q3 2018.
  • 164 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2019.

Based on Scout Investments's 13F filing for Q1 2019, filed 12 Apr 2019.